Control of interleukin 1 (IL-1) activity. I. Inhibition of IL-1 activity bysoluble immune response suppressor (SIRS) in vitro

• Autorzy: Zimecki M. , Wieczorek Z. , Pierce C.W. , Kapp J.A. , Schnaper H.W. , Schnaper H.W. , Webb D.R.
• Języki publikacji: EN

Abstrakty

EN

• Wydawca: -
• Czasopismo: Archivum Immunologiae et Therapiae Experimentalis
• Rocznik: 1991
• Tom: 39
• Numer: 3
• Opis fizyczny: p.213-226,fig.,ref.

Twórcy

autor

Zimecki M.

• Department of Experimental Therapy, The Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Czerska 12, 53-114 Wroclaw, Poland

autor

Wieczorek Z.

• Department of Experimental Therapy, The Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Czerska 12, 53-114 Wroclaw, Poland

autor

Pierce C.W.

• Department of Pathology, The Jewish Hospital of St. Louis, 216 S.Kingshighway, St.Louis, MO 63110, USA

autor

Kapp J.A.

• Department of Pathology, The Jewish Hospital of St. Louis, 216 S.Kingshighway, St.Louis, MO 63110, USA

autor

Schnaper H.W.

• Department of Pathology, The Jewish Hospital of St. Louis, 216 S.Kingshighway, St.Louis, MO 63110, USA

autor

Schnaper H.W.

• Department of Pediatrics, Washington University School of Medicine, St.Louis, MO 63110, USA

autor

Webb D.R.

• Department of Molecular Immunology, Syntex Research, Palo Alto, CA 94304, USA